FIG. 3.
ABCG2 mRNA expression levels in imatinib-exposed samples according to the treatment outcomes of dasatinib (n=10). ABCG2 mRNA expression levels in imatinib-exposed samples in patients achieving CCyR and no CCyR (A), MMR or no MMR (B), and optimal response or failure (C). CCyR: complete cytogenetic response, MMR: major molecular response, pos: positive, neg: negative.